Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-13-047176
Filing Date
2013-09-03
Accepted
2013-09-03 11:07:01
Documents
2
Period of Report
2013-08-22

Document Format Files

Seq Description Document Type Size
1 rrd389566.html 3  
1 rrd389566.xml 3 1583
2 POWER OF ATTORNEY rrd350471_396794.htm EX-24. 2770
  Complete submission text file 0001181431-13-047176.txt   5877
Mailing Address C/O TRANSKARYOTIC THERAPIES INC 700 MAIN STREET CAMBRIDGE MA 02139
Business Address
ASTRUE MICHAEL J (Reporting) CIK: 0001236367 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-52089 | Film No.: 131074163

Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Issuer) CIK: 0001292519 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus